Scientists at the University of Sheffield have discovered how a dangerous fungus disables the immune system’s frontline defenders, neutrophils. The finding could lead to new therapies for fighting drug-resistant fungal infections, often called superbugs. According to a report on Medical Xpress, the research reveals a previously unknown mechanism of immune evasion.

Key takeaways

  • A fungus deadly to people with weakened immune systems can disable neutrophil extracellular traps (NETs), a critical immune defense.
  • The fungus prevents neutrophils from forming these net like structures, allowing the infection to spread.
  • This discovery opens the door to developing drugs that restore NET function and help the body fight off superbugs.

Understanding the fungus and its threat

The fungus studied by the Sheffield team is particularly dangerous for individuals with compromised immune systems, such as those undergoing chemotherapy, organ transplant recipients, or people living with HIV. These infections can become life threatening and are increasingly resistant to existing antifungal medications. The U.S. Centers for Disease Control and Prevention has classified certain drug resistant fungi as urgent public health threats.

How neutrophils fight infection

Neutrophils are white blood cells that act as the body’s first line of defense against invading microbes. One of their most powerful weapons is the release of neutrophil extracellular traps, or NETs. These are web like structures made of DNA and antimicrobial proteins that capture and kill bacteria, fungi, and other pathogens. Until now, scientists believed that most fungi could not evade this defense.

The new discovery: blinding the immune system

The University of Sheffield researchers found that the fungus can actively block the formation of NETs. In laboratory experiments, neutrophils exposed to the fungus failed to produce the net like traps that normally ensnare and destroy microbes. The fungus essentially “blinds” the immune system by disabling this key weapon. The exact molecular mechanism involves signals that the fungus releases to interrupt the neutrophil’s internal instructions for building NETs, according to the Medical Xpress report.

Implications for treating superbugs

This finding is important because it reveals a specific vulnerability that could be targeted by new drugs. Instead of developing stronger antifungals that the microbes might eventually resist, scientists could create treatments that help the immune system do its job. For example, a drug that prevents the fungus from blocking NET formation could restore the body’s natural ability to clear the infection. The researchers suggest this approach could be especially useful for patients with weakened immunity who cannot rely on their own defenses alone.

What the researchers say

According to the report, the lead researcher stated that the team was surprised to see how effectively the fungus neutralized neutrophils. “We have identified a mechanism that the fungus uses to evade our immune defenses. This opens up new avenues for treatment that could help patients at highest risk,” the researcher said. The team is now working to identify the exact molecules involved and to test potential inhibitors.

Frequently Asked Questions

What is the name of the fungus?

The research focuses on Candida albicans, a common fungus that can cause life threatening infections in people with weakened immune systems. It is a leading cause of hospital acquired bloodstream infections.

How does the fungus blind neutrophils?

It prevents the formation of neutrophil extracellular traps (NETs), which are net like structures that capture and kill microbes. By blocking NET production, the fungus avoids being trapped and destroyed by the immune system.

Could this lead to new treatments?

Yes, scientists hope to develop drugs that block the fungus’s ability to disable NETs. Such treatments could help the immune system fight off the infection, especially in patients whose own defenses are weak. This approach may also reduce the risk of drug resistance.

This is an original report by Vital Signs Today, informed by reporting from Medical Xpress. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.